Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Advanced BioHealing, Inc.

Latest From Advanced BioHealing, Inc.

Start-Up Previews (6/06)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, New Devices for Varicose Veins, features profiles of Vascular Insights, VeinRx and Venousonics. Plus these Start-Up Across Health Care: NanoMed Pharmaceuticals, Peakadilly, Quincy Bioscience and Solidus Biosciences.

VeinRx Inc.

VeinRx's balloon-controlled venous ablation technology is designed to address both the medical and cosmetic varicose vein markets. It is a single-use, catheter-based product for delivering a sclerosant to the diseased vein. The balloon prevents the chemical from migrating out of the treatment zone. Physicians thus have greater control over both the dosage and the treatment area. There's also a potential safety benefit since the sclerosing agent cannot disperse into the general circulation.

Medical Device

New Devices for Varicose Veins

There's nothing even remotely sexy about varicose veins. Yet medical device companies and their investors are starting to view the opportunity for treating these bulging blue leg veins as downright alluring. The recent introduction of minimally invasive technologies, combined with shifting demographics and favorable reimbursements, are fueling talk of blockbuster potential for this hybrid clinical/cosmetic market.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Biomaterials
  • Biotechnology
    • Gene Therapy, Cell Therapy